Concord Medical changes CFO leadership roles

Concord Medical Services Holdings reported a leadership change in its finance team.

Rhea-AI Filing Summary

Concord Medical Services Holdings reported a leadership change in its finance team. Mr. Wei Jiang stepped down as chief financial officer effective June 30, 2026 to focus on the business and operations of Concord Healthcare Group, the Company’s Hong Kong–listed subsidiary.

The Company appointed Mr. Botao Shi as interim chief financial officer effective the same date. Shi has long experience within Concord Medical and Concord Healthcare Group, including roles as vice president, board secretary, and director. The Company stated that Jiang’s resignation did not result from any disagreement over operations, policies, practices, or financial reporting.

Insights

Corporate governance analyst

CFO change appears orderly and internally sourced, with limited disclosed friction.

Concord Medical announced that Wei Jiang left the chief financial officer role on June 30, 2026 to focus on subsidiary Concord Healthcare Group, while remaining within the broader corporate structure. The Company explicitly states there was no disagreement over operations or financial reporting.

The interim CFO, Botao Shi, has a long tenure across Concord entities, covering equity management, investment and financing, and prior board secretary roles. This internal appointment suggests continuity in financial oversight, though long-term plans for a permanent CFO are not discussed in the excerpt.

Subsequent disclosures in future company filings may clarify whether Shi remains in the role or if a permanent external or internal candidate is selected, which would further define the company’s long-term finance leadership structure.

Key Figures

CFO resignation effective date: June 30, 2026 Interim CFO appointment date: June 30, 2026 Master’s degree year: June 2013

3 metrics

CFO resignation effective date June 30, 2026 Wei Jiang stepped down as CFO effective this date

Interim CFO appointment date June 30, 2026 Botao Shi appointed interim CFO effective same date

Master’s degree year June 2013 Botao Shi obtained a master’s degree in business management

Key Terms

interim chief financial officer, forward-looking statements, non-executive director, board secretary

4 terms

interim chief financial officer financial

"the appointment of Mr. Botao Shi as the Company’s interim chief financial officer"

An interim chief financial officer is a temporary leader responsible for managing a company's financial activities, such as budgeting, financial planning, and reporting, during a transitional period. Think of it as filling in for a key manager until a permanent replacement is found. For investors, this role is important because it ensures financial stability and clear guidance during times of change or uncertainty.

forward-looking statements regulatory

"This report contains forward-looking statements within the meaning of Section 21E"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

non-executive director financial

"He concurrently serves as a non-executive director of Concord Healthcare Group"

A non-executive director is a member of a company’s board who does not work for the company day-to-day but provides independent oversight, strategic guidance and checks on management. For investors, they matter because they act like an impartial referee or outside advisor, helping ensure decisions protect shareholder interests, reduce risks of poor governance, and add credibility to financial reporting and long-term strategy.

board secretary financial

"served as its board secretary from that date until August 28, 2024"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What management change did Concord Medical (CCM) announce in this 6-K?

Concord Medical announced that Wei Jiang stepped down as chief financial officer effective June 30, 2026. The company simultaneously appointed Botao Shi as interim chief financial officer, ensuring continuity in its finance function while Jiang focuses on the group’s Hong Kong–listed subsidiary.

Why did Wei Jiang resign as CFO of Concord Medical (CCM)?

Wei Jiang resigned as chief financial officer to devote his time and focus to Concord Healthcare Group Co., Ltd., the Company’s subsidiary listed in Hong Kong. The filing notes his resignation was not due to any disagreement over operations, policies, practices, or financial reporting matters.

Who is the new interim CFO of Concord Medical (CCM) and what is his background?

Concord Medical appointed Botao Shi as interim chief financial officer effective June 30, 2026. Shi has served as vice president and board secretary, previously led equity management and investment and financing, and held executive and non-executive director roles at Concord Healthcare Group since 2015.

Did Concord Medical (CCM) report any disputes related to the CFO’s resignation?

The company stated that Wei Jiang’s resignation did not result from any disagreement with Concord Medical on operations, policies, practices, or financial reporting. This suggests the change is framed as an orderly transition rather than one driven by internal conflict or accounting concerns.

What roles has Botao Shi held within Concord Medical and its subsidiary?

Botao Shi has been vice president and board secretary of Concord Medical since August 2024, overseeing equity management and investment and financing. At Concord Healthcare Group, he has served as board secretary, executive director, and later non-executive director, demonstrating broad governance and financial experience.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 07:07 AM Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number: 001-34563

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

Room A1-A5 26/F, East Zone, Hanwei Plaza

No. 7 Guanghua Road, Chaoyang District,

Beijing 100020

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x        Form 40-F ¨

Concord Medical Announces Changes in Management

Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that Mr. Wei Jiang stepped down as chief financial officer of the Company, effective June 30, 2026. The Company further announced the appointment of Mr. Botao Shi as the Company’s interim chief financial officer, effective on the same date.

Mr. Wei Jiang has resigned from his role as the chief financial officer of the Company in order to devote his time and focus to the business and operations of Concord Healthcare Group Co., Ltd. (“Concord Healthcare Group”), the Company's subsidiary listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 2453.HK. Mr. Jiang’s resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies, practices, or financial reporting, including its accounting principles and practices.

“We would like to express our sincere gratitude to Mr. Wei Jiang for all his efforts and contributions over the past years,” commented Dr. Jianyu Yang, chairman and chief executive officer of the Company. “In the meantime, we are pleased to announce the appointment of Mr. Botao Shi as our interim chief financial officer. We look forward to working closely with Mr. Shi to continue to create value for our shareholders.”

Mr. Botao Shi has served as vice president and secretary of the board of Concord Medical since August 29, 2024, with primary responsibility for the Company's equity management and investment and financing matters. He concurrently serves as a non-executive director of Concord Healthcare Group. Mr. Shi joined Concord Healthcare Group on August 27, 2015 and served as its board secretary from that date until August 28, 2024. He was appointed an executive director of Concord Healthcare Group on June 20, 2023, a position he held until August 28, 2024, when he was re-designated as a non-executive director effective August 29, 2024. Prior to joining Concord Healthcare Group, Mr. Shi served as board secretary and general manager of the Asset Management Department of Concord Medical from October 2007 to July 2015. Mr. Shi obtained a master's degree in business management from Beijing Institute of Technology in June 2013.

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company's actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

	By:	/s/ Jianyu Yang
	Name:	Jianyu Yang
	Title:	Chairman and Chief Executive Officer

Date: July 2, 2026